XNAS · HRTX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Heron Therapeutics, Inc.

Heron Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS
$0.4384

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is HRTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Heron Therapeutics, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
1987
Employees
128
Country
US

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.4384
Last session
Day high
$0.4384
Last session
Day low
$0.4384
Last session
Previous close
$0.4384
52W high
$0.4386
-0.05% from high
52W low
$0.3855
100% of range
Market cap
$83M
EPS
$-0.1500
Shares out
189.3M
VWAP
$0.4384
Last session
Price history computed in-house
1W
+3.47%
SMA 50 $0.4182 · above
SMA 200 $0.4182 · above
52W position 100%
Veridion warehouse edge

Warehouse intelligence for HRTX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

HRTX insider activity

Heron Therapeutics, Inc.

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for HRTX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

HRTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HRTX in this window.
Lobbying spend

HRTX lobbying filings, year to date.

Registered lobbying filings matched to Heron Therapeutics, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HRTX in this window.
Latest news · HRTX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for HRTX.
Options
Sovereign unlock shows live options positioning for HRTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.